SCHEMBL17931583

SCHEMBL17931583

Cc1ccc(COc2ccc(C)c(C)c2)cc1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.55
NPC1 O15118 4/20 0.55
HSP90AA1 P07900 1/20 0.55
MAPT P10636 1/20 0.51
HRH3 Q9Y5N1 1/20 0.51
GAA P10253 1/20 0.50
HPGD P15428 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ESR1 P03372 1/20 0.50
TP53 P04637 1/20 0.50
POLB P06746 1/20 0.50
APEX1 P27695 1/20 0.50
MAPK1 P28482 1/20 0.50
ESR2 Q92731 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
APP P05067 3/20 0.47
LMNA P02545 1/20 0.45
RECQL P46063 1/20 0.45
MAOB P27338 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12337966 0.94 RAB9A (0.57) RAB9ANPC1HSP90AA1MAPTHRH3
SCHEMBL13929699 0.88 MAOB (0.53) RAB9ANPC1HSP90AA1MAPTHRH3
SCHEMBL13401924 0.88 MAOB (0.59) RAB9ANPC1HSP90AA1HRH3GAA
SCHEMBL8335885 0.84 ALOX5 (0.61) RAB9ANPC1HSP90AA1MAPTHRH3
SCHEMBL10397557 0.84 NPC1 (0.60) RAB9ANPC1HSP90AA1MAPTHRH3
SCHEMBL5540184 0.81 APP (0.41) RAB9ANPC1HSP90AA1MAPTHRH3
SCHEMBL2553220 0.81 ENPP2 (0.51) RAB9ANPC1HSP90AA1MAPTHRH3
SCHEMBL2560717 0.81 RAB9A (0.50) RAB9ANPC1HSP90AA1MAPTHRH3
SCHEMBL25721889 0.81 FFAR1 (0.53) MAOBMRGPRX4
SCHEMBL18270011 0.80 PARP10 (0.46) RAB9ANPC1HSP90AA1SMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160207878-A1 MAO-B Selective Inhibitor Compounds, Pharmaceutical Compositions Thereof and Uses Thereof THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2016-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160207878-A1 MAO-B Selective Inhibitor Compounds, Pharmaceutical Compositions Thereof and Uses Thereof MAOB, MAOA, COMT RAB9A 2129/4885NPC1 1244/4885HSP90AA1 2475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.